SCHEMBL7744306

SCHEMBL7744306

CCCCc1nc2c(c(=O)[nH]c(=O)n2Cc2ccccc2)n1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 0.50
▸ MEN1 O00255 6/20 0.50
▸ ALDH1A1 P00352 7/20 0.42
▸ KDM4E B2RXH2 6/20 0.42
▸ MAPT P10636 3/20 0.42
▸ PKM P14618 2/20 0.42
▸ MCL1 Q07820 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ CACNA1B Q00975 1/20 0.42
▸ APBA1 Q02410 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ HTT P42858 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ TPH1 P17752 2/20 0.40
▸ TPH2 Q8IWU9 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8982506 0.87 MEN1 (0.43) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL7743868 0.71 PDE4A (0.46) ALDH1A1PKMHTTPDE4APDE4B
SCHEMBL7743866 0.71 PDE4A (0.46) ALDH1A1PKMHTTPDE4APDE4B
SCHEMBL7744419 0.69 PDE4A (0.47) KMT2AALDH1A1PKMPDE4APDE4B
SCHEMBL7744421 0.69 PDE4A (0.47) KMT2AALDH1A1PKMPDE4APDE4B
SCHEMBL21389577 0.68 MEN1 (1.00) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL18159000 0.64 HPGD (0.49) HPGD
SCHEMBL15810628 0.64 HPGD (0.49) HPGD
SCHEMBL15798913 0.64 HPGD (0.49) HPGD
SCHEMBL18852587 0.64 HPGD (0.49) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0708781-B1 A 3 ADENOSINE RECEPTOR AGONISTS USA (US) 2001-10-04 — — EP disclosed
EP-0708781-A1 A 3 ADENOSINE RECEPTOR AGONISTS THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) 1996-05-01 — — EP disclosed
Send feedback